- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Genotyping of SIRT1in Chronic Obstructive Pulmonary Disease in Hungary
Total 159 results
-
Chiesi Farmaceutici S.p.A.CompletedChronic Obstructive Pulmonary DiseaseHungary
-
Chiesi Farmaceutici S.p.A.CompletedChronic Obstructive Pulmonary DiseaseHungary
-
Chiesi Farmaceutici S.p.A.CompletedChronic Obstructive Pulmonary DiseaseItaly, Germany, Hungary
-
Szeged UniversityCompletedCOPD Postural Control IMTHungary
-
Chiesi Farmaceutici S.p.A.CompletedChronic Obstructive Pulmonary DiseaseBelgium, Hungary
-
Chiesi Farmaceutici S.p.A.CompletedModerate to Severe Chronic Obstructive Pulmonary Disease (COPD)Bulgaria, Germany, Hungary, Poland, Russian Federation, United Kingdom
-
Chiesi Farmaceutici S.p.A.CompletedChronic Obstructive Pulmonary DiseaseBelgium, Hungary
-
AstraZenecaCompletedScientific Terminology Chronic Obstructive Pulmonary Disease (COPD) | Laymen Terminology Chronic Bronchitis and EmphysemaBulgaria, Germany, Hungary, Ukraine
-
AstraZenecaCompletedChronic Obstructive Pulmonary DiseaseBulgaria, Germany, Hungary, Finland, Slovakia
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease | COPDAustria, France, Hungary, Italy, Poland, Portugal, Russian Federation, South Africa, Spain, Canada, United Kingdom, Australia, Netherlands, Switzerland
-
NovartisCompletedChronic Obstructive Pulmonary DiseaseGermany, United States, Belgium, Hungary
-
Mundipharma Research LimitedCompletedChronic Obstructive Pulmonary DiseaseUkraine, United Kingdom, Spain, Bulgaria, South Africa, Russian Federation, Germany, Hungary, Lithuania, Slovakia, Macedonia, The Former Yugoslav Republic of, Latvia, Romania, Korea, Republic of, Poland
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary DiseaseUnited States, Germany, Hungary, Belgium, Poland, Spain, Netherlands
-
Ionis Pharmaceuticals, Inc.TerminatedChronic Obstructive Pulmonary Disease | Chronic BronchitisGermany, Czechia, Hungary, United Kingdom
-
Chiesi Farmaceutici S.p.A.CompletedChronic Obstructive Pulmonary Disease (COPD)Czechia, Germany, Hungary, Romania
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary Disease (COPD)Spain, Germany, Estonia, Hungary, Belgium, Czech Republic, Norway, Korea, Republic of, Lithuania
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease (COPD)Czech Republic, Germany, Hungary, Poland
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveHungary, Slovakia
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveAustria, Czechia, Hungary, Israel, Romania, Russian Federation, Slovakia, Slovenia, Switzerland
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease (COPD)Germany, Czech Republic, France, Hungary, Italy, Peru, Poland, Russian Federation, South Africa, Spain, Ukraine
-
AstraZenecaParexel International Ltd; Cognizant Technology Solution; Center for Information... and other collaboratorsCompletedChronic Obstructive Pulmonary Disease COPDUnited States, Canada, France, Russian Federation, Ukraine, Hungary, Bulgaria
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveBelgium, Denmark, Germany, Hungary
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary DiseaseRomania, Lithuania, Canada, France, Hungary, India, South Africa, Korea, Republic of, Latvia, United Kingdom
-
Sunovion Respiratory Development Inc.CompletedChronic Obstructive Pulmonary Disease (COPD)United States, Czechia, Hungary, Russian Federation
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary Disease (COPD)Colombia, India, Korea, Republic of, Poland, Croatia, Estonia, Hungary, United Kingdom, Israel, Latvia, Turkey, Argentina, Panama, Mexico, Russian Federation, Serbia, Slovenia
-
NovartisCompletedChronic Obstructive Pulmonary Disease (COPD)Russian Federation, Germany, Denmark, Italy, Canada, Czech Republic, Hungary, India, Slovakia, France, Colombia, Finland, Taiwan, Iceland, Peru
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease (COPD)France, Germany, United Kingdom, United States, Australia, Austria, Brazil, Hungary, New Zealand, Romania, Russian Federation
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease, COPDSweden, France, Germany, Hungary, Poland, Canada, Australia, Slovakia, Spain
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease (COPD)Bulgaria, Czech Republic, Poland, Hungary, Romania, Slovakia
-
Hoffmann-La RocheCompletedChronic Obstructive Pulmonary DiseaseUnited States, Canada, Bulgaria, Hungary, Russian Federation, Denmark, Argentina, Mexico, Poland
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary Disease (COPD)United States, Colombia, Spain, Canada, Slovakia, India, Netherlands, Czech Republic, Hungary
-
PfizerCompletedChronic Obstructive Pulmonary DiseaseAustralia, Netherlands, Canada, Korea, Republic of, Argentina, Hungary, South Africa, France, Russian Federation, Chile, Czechia, Greece, United Kingdom
-
Zuzana Zbožínková, M.Sc.Boehringer IngelheimCompletedChronic Obstructive Pulmonary DiseaseLatvia, Croatia, Austria, Bulgaria, Czech Republic, Hungary, Poland, Russian Federation, Serbia, Slovakia, Slovenia
-
AstraZenecaRecruitingCOPD (Chronic Obstructive Pulmonary Disease)United States, Korea, Republic of, Argentina, Turkey, Vietnam, Malaysia, Philippines, Thailand, Hungary, Mexico, Bulgaria, Canada, India, Poland
-
MedImmune LLCCompletedChronic Obstructive Pulmonary DiseaseUnited States, Bulgaria, Czech Republic, Poland, United Kingdom, Philippines, Latvia, Lithuania, Ukraine, Hungary
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease (COPD)Austria, Belgium, Bulgaria, Croatia, Czech Republic, Denmark, Finland, France, Germany, Hungary, Italy, Korea, Republic of, Netherlands, Poland, Romania, Russian Federation, Slovakia, South Africa, Spain, Sweden, Ukraine, United Kingdom
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary DiseaseGermany, Poland, Romania, Hungary, Sweden, Russian Federation, Bulgaria, Finland, Israel, Belgium
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary Disease (COPD)Greece, Belgium, Bulgaria, Turkey, Hungary, Slovakia, Spain, United Kingdom, Russian Federation, Ireland
-
Janssen Research & Development, LLCCompletedChronic Obstructive Pulmonary DiseaseUnited Kingdom, United States, Belgium, Germany, Romania, Canada, Netherlands, Russian Federation, Poland, Hungary, Czechia
-
AstraZenecaCompletedChronic Obstructive Pulmonary DiseaseFrance, Germany, Italy, Spain, United Kingdom, Austria, Hungary
-
AstraZenecaRecruitingChronic Obstructive Pulmonary Disease (COPD)United States, Canada, Czechia, Denmark, Hungary, Netherlands, Spain, Korea, Republic of, Argentina, Belgium, Bulgaria, Finland, India, Japan, Mexico, Norway, Sweden, Turkey, Vietnam, Portugal, Puerto Rico
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease (COPD)Austria, Bulgaria, Canada, Czech Republic, France, Germany, Hungary, Italy, Lithuania, Netherlands, Poland, South Africa, Spain, United Kingdom
-
AstraZenecaRecruitingChronic Obstructive Pulmonary Disease (COPD)China, Denmark, United States, Australia, Canada, Germany, Netherlands, Poland, Spain, United Kingdom, Korea, Republic of, Philippines, Italy, Argentina, Belgium, Bulgaria, Czechia, Finland, Hungary, India, Japan, Mexico, Norway, Port... and more
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease (COPD)Bulgaria, France, Italy, Poland, Russian Federation, Ukraine, Hungary, Slovakia
-
AstraZenecaCompletedChronic Obstructive Pulmonary DiseaseUnited States, Germany, Poland, Israel, Bulgaria, Czechia, Hungary, Spain, Ukraine, United Kingdom
-
AstraZenecaMedImmune LLCCompletedModerate to Very Severe Chronic Obstructive Pulmonary DiseaseUnited States, Canada, Germany, Italy, Netherlands, Spain, United Kingdom, Poland, Japan, Austria, Korea, Republic of, Russian Federation, South Africa, Czechia, Hungary, Romania, Switzerland
-
NovartisCompletedChronic Obstructive Pulmonary DiseaseRussian Federation, United Kingdom, Spain, Germany, Argentina, Italy, Netherlands, Switzerland, Turkey, France, Czech Republic, Hungary, Slovakia, Peru, Korea, Republic of, Colombia, Israel, Chile, Denmark, Ecuador, Egypt, Estonia, ... and more
-
AstraZenecaRecruitingChronic Obstructive Pulmonary Disease (COPD)China, United States, Denmark, Italy, Canada, Germany, Hungary, Netherlands, Spain, United Kingdom, Belgium, Argentina, Bulgaria, India, Japan, Vietnam, Malaysia, Thailand, Korea, Republic of, Mexico, Brazil, Greece, Poland, France, Peru, Chil... and more
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease (COPD) | Chronic BronchitisUnited States, Canada, Denmark, Spain, United Kingdom, Taiwan, New Zealand, Australia, Germany, Israel, South Africa, Czechia, Hungary, Poland, Netherlands
-
SanofiRegeneron PharmaceuticalsRecruitingChronic Obstructive Pulmonary DiseaseUnited States, Argentina, Bulgaria, Chile, China, Czechia, Hungary, Israel, Poland, Taiwan, Canada, Portugal, United Kingdom, Korea, Republic of, Japan, Slovakia, South Africa